Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Hormel Foods
HRL
$14.2B
| $73.1M | 0.04% |
1,495,669
-53,595
| -3% | -$2.69M |
|
402
Universal Display
OLED
$3.75B
| $72.4M | 0.04% |
400,304
+385,167
| +2,545% | +$65.8M |
|
|
FMTX
403
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $72.2M | 0.04% |
1,479,342
+488,297
| +49% | +$19.7M |
|
|
EGRX
404
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $72.2M | 0.04% |
1,698,737
-7,907
| -0.5% | -$346K |
|
|
JBTM
405
JBT Marel
JBTM
$7.35B
| $71.4M | 0.04% |
777,292
-138,779
| -15% | -$13.3M |
|
406
Chipotle Mexican Grill
CMG
$43.9B
| $71.4M | 0.04% |
2,871,200
-670,050
| -19% | -$16.1M |
|
407
PagerDuty
PD
$830M
| $71.4M | 0.04% |
2,632,015
-3,061
| -0.1% | -$86.1K |
|
|
CDK
408
DELISTED
CDK Global, Inc.
CDK
| $70.3M | 0.04% |
1,612,467
+831,306
| +106% | +$37M |
|
409
SBA Communications
SBAC
$19.8B
| $69.8M | 0.04% |
219,417
-29,379
| -12% | -$8.98M |
|
410
Itron
ITRI
$4.48B
| $69.8M | 0.04% |
1,149,292
-90,032
| -7% | -$5.72M |
|
411
Moody's
MCO
$83.7B
| $69.5M | 0.04% |
239,928
-22,304
| -9% | -$6.37M |
|
|
SILK
412
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $69.4M | 0.04% |
1,033,251
-344,177
| -25% | -$18.8M |
|
|
CTXS
413
DELISTED
Citrix Systems Inc
CTXS
| $68.7M | 0.04% |
499,204
-19,915
| -4% | -$2.85M |
|
414
Zillow
Z
$7.78B
| $68.7M | 0.04% |
676,550
+404,193
| +148% | +$31.6M |
|
415
Descartes Systems
DSGX
$6.68B
| $68.1M | 0.04% |
1,199,535
-117,977
| -9% | -$6.53M |
|
416
Everest Group
EG
$15.6B
| $68.1M | 0.04% |
344,790
+87,680
| +34% | +$18.8M |
|
417
Ciena
CIEN
$46.8B
| $68.1M | 0.04% |
1,715,272
-41,207
| -2% | -$2.17M |
|
418
JD.com
JD
$43.5B
| $67.9M | 0.04% |
875,229
+386,367
| +79% | +$26.8M |
|
419
Travere Therapeutics
TVTX
$5.17B
| $67.5M | 0.04% |
3,657,157
+745,088
| +26% | +$14.5M |
|
|
DGNR.U
420
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
| $67.4M | 0.04% |
+5,500,000
| New | +$65.2M |
|
421
NetEase
NTES
$83B
| $66.7M | 0.03% |
733,645
-115,215
| -14% | -$10.8M |
|
422
Constellium
CSTM
$3.76B
| $66.5M | 0.03% |
8,467,591
+286,350
| +4% | +$2.37M |
|
423
Vail Resorts
MTN
$5.7B
| $66.4M | 0.03% |
310,369
-121,354
| -28% | -$25M |
|
424
DTE Energy
DTE
$29.9B
| $66.4M | 0.03% |
678,179
+4,707
| +0.7% | +$460K |
|
425
Wolfspeed
WOLF
$1.04B
| $66.2M | 0.03% |
1,038,032
-506,000
| -33% | -$32.8M |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.